%0 Journal Article
%T Economic Burden Can Be the Major Determining Factor Resulting in Short-Term Intermittent and Repetitive Ustekinumab Treatment for Moderate-to-Severe Psoriasis
%A Bo Ri Kim
%A Chong Won Choi
%A Ji Young Choi
%A Sang Woong Youn
%J Archive of "Annals of Dermatology".
%D 2018
%R 10.5021/ad.2018.30.2.179
%X The continuous use of biologic agents in the treatment of psoriasis has been reported to result in successful and sustained therapeutic effects and safety. However, some patients choose intermittent and repetitive treatment
%K Cost of illness
%K Drug administration schedule
%K Insurance
%K Psoriasis
%K Ustekinumab
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839889/